Stocks Snap Latest Winning Streak

Accenture's AI boost, Jabil's latest warning, and Darden's latest consumer read.

NEWS
Stocks Snap Latest Winning Streak

Nvidia giveth, and Nvidia taketh away. The world’s most valuable stock pulled the broader market lower as the S&P 500 snapped its seven-day win streak. Notably, Stocktwits sentiment for all the major indexes closed in bearish or extremely bearish territory. Let’s see what you missed. 👀

Today's issue covers Darden’s current read on the consumer, Accenture’s AI revenue boost, and manufacturer Jabil’s latest warning. 📰

Here's today's heat map:

8 of 11 sectors closed green. Energy (+1.84%) led, & technology (-1.12%) lagged. 💚

Central bank actions continue to diverge. The Bank of England kept rates at 5.25% amid sticky inflation, aiming for an August cut. Meanwhile, Switzerland made its second 25 bp cut of the year, with inflation at 1.40%. ✂️

The NAHB housing market index fell to its lowest level of the year, as mortgage rates above 7% and elevated construction financing kept a lid on builder confidence. Building permits also fell to a nearly 4-year low during May, falling 3.80% MoM and 9.50% YoY. U.S. housing starts also fell 5.50% in May, their lowest since June 2020, on the back of weak multifamily starts. 🏘️

Homebuilder KB Home jumped 3% after its revenue and earnings topped expectations, noting that net orders rose 2% YoY. It’s continuing to focus on first-time homebuyers with lower-priced, affordable options. 🔺

The Philadelphia Fed manufacturing index was steady in June, marking its fifth straight month in positive territory. As economic activity holds up, crude oil and the energy complex continue to rise amid falling inventories. 🛢️

European political turmoil caused luxury sneaker maker Golden Goose to call off its roughly $2 billion initial public offering (IPO). It comes as 2024 is on pace to be the slowest year for European IPOs in the past decade. 🙃

Gilead Sciences rose 7% after its twice-yearly shot to prevent HIV succeeded in a late-stage trial of roughly 2,000 women. It must replicate the results before seeking FDA approval, but the treatment could hit shelves in late 2025. 👍

Sarepta Therapeutics soared 40% after receiving broad approval for its muscular dystrophy drug, expanding access to all patients who can walk. 💊

Honeywell shares popped on news it will buy aerospace and defense technology provider CAES Systems for $1.90 billion in cash. 🛡️

Electric vehicle maker Nikola plunged 31% after announcing a 1-for-30 reverse split, as fears remain high following Fisker’s bankruptcy. 🪫

Winnebago Industries fell to 18-month lows after earnings and revenue fell YoY and missed analyst expectations. Concerns are the slowing economy will weigh heavily on large discretionary purchases like RVs. 🚙

Penn Entertainment shares rose 10% on news that Boyd Gaming is exploring a potential acquisition. It would be the biggest merger among U.S. gambling companies since Eldorado Resort’s $17.30 billion purchase of Caesars. 🎰

Although the crypto market continues to melt lower, MicroStrategy completed the purchase of $786 million worth of Bitcoin using its convertible note proceeds. And crypto’s mainstream adoption continues, with Australia’s main stock market listing its first Bitcoin exchange-traded fund (ETF). ₿

Other active symbols: $DJT (-14.56%), $CMG (-6.22%), $AMD (+4.62%), $TPST (-29.47%), $HIMS (-9.68%), and $NNE (+31.21%). 🔥

Here are the closing prices: 

S&P 500

5,473

-0.25%

Nasdaq

17,722

-0.79%

Russell 2000

2,017

-0.39%

Dow Jones

39,135

+0.77%

EARNINGS
Food Stocks Flag Latest Consumer Trends

Olive Garden parent Darden Industries is one of many restaurant stocks used as a proxy for the health of the U.S. consumer. Its diversified portfolio stretches across dining experiences and income levels, giving investors and traders a read into where people are spending their discretionary income. 🕵️

Today we heard a similar story from the company, which reported adjusted earnings per share that topped expectations, while revenues missed by a hair. Same-store sales were also flat YoY, with sales at Olive Garden and its fine-dining restaurants failing to keep pace with estimates.

Executives repeated a line we’ve heard for many quarters now: consumers are growing concerned about inflation. But these days, they’re also concerned about the job market, which continues thawing from historically hot levels. 😬

Despite the sales slowdown, Darden is opting not to play the “sales and promotions” game its competitors are. Instead, it’s betting its strong offerings will continue to lure consumers in, and full-priced items will buoy margins.

As for bright spots, LongHorn Steakhouse remains the key growth driver of the portfolio, seeing same-store sales rise 4% (the only property to grow). 🥩

However, looking ahead, its full-year earnings and sales forecast were on the lower end of analyst expectations, with its CFO projecting 3% inflation and same-store sales growth of 1%-2% in fiscal 2025.

Shares were up marginally on the day and continue consolidating about 10% below all-time highs. Stocktwits community sentiment seems to be in line with management’s upbeat outlook, sitting in extremely bullish territory. 🐂

SPONSORED
Earn rebates on every options contract traded at Public.com

Are you an options trader? At Public.com , you'll earn a rebate on every contract traded with no commissions or per-contract fees. That's because Public offers a rebate on every contract you buy or sell. Joining Public is easy, and your rebates can add up fast. If you trade 1,000 option contracts on Public, you'll earn $60 to $180 in rebates and avoid up to $1,000 in fees that other platforms charge.

So, don’t change your strategy; change your platform—and start earning rebates on every options contract traded. Plus, get up to $10,000 when you transfer your existing portfolio to Public. 

Discover why NerdWallet recently awarded Public five stars for options trading (and 4.6/5 stars overall), and earn rebates on options trades with no commissions or per-contract fees.

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

Subscribe to keep reading

This content is free, but you must be subscribed to The Daily Rip to continue reading.

I consent to receive newsletters via email. Sign Up Terms of Service.

Already a subscriber?Sign In.Not now

Reply

or to participate.